Like cannabis, wealthy investors are shoving millions of dollars into psychedelics - GoFuckYourself.com

wehateporn · 10-15-2017, 02:20 AM

This is a story about business, not about drugs. It's about a new field that will likely flourish in the next decade or two, one selling mushrooms and other psychedelics as legally as alcohol and marijuana are today. There will be DMT retreat centers, doctors who administer LSD microdoses, and centers that use ketamine to permanently cure depression.

But first, to convince you this business is important, this business will matter to regular people, a tale must first be told: about a "sweet old lady" (as her friend calls her, despite her being only 59) who was once afraid of death.

Diane Dodge was always straightlaced. She was a systems analyst. A college grad. A rule follower. But after doctors told her she'd be dead in three years from colorectal cancer, she decided it was time to do drugs.

Much like the cancer, the anxiety of dying was also killing her. In the beginning, she thought about simply offing herself to get it over with. Then, she read an article in The New Yorker by Michael Pollan titled, "The Trip Treatment," which highlighted studies from Johns Hopkins and NYU showing that after a single dose of psilocybin mushrooms, cancer patients "who had been palpably scared of death, they lost their fear" ? as researcher Stephen Ross of NYU told Pollan.

"The fact that a drug given once can have such an effect for so long is an unprecedented finding,? Ross continued. ?We have never had anything like it in the psychiatric field.?

Diane Dodge wanted in. She lived in North Carolina, but called the distant university to offer herself as a subject anyway. They were full. This is where corporate industry stepped in. Business. By chance, Dodge found a newly created business that was going to help her.

It was MycoMeditations, a company founded by a man named Eric Osborne that runs five-day mushroom trip getaways starting at just $1995. The price includes a room, two meals a day and a few opportunities to do mushrooms while sitting around a campfire on the beach. Because it?s in Jamaica, it?s perfectly legal, a fact Osborne caught wind of after being arrested for growing mushrooms in America years ago.

Dodge went. She did drugs. As waves crashed on the beach, waves of light crashed inside her head. She hallucinated children, elves. "You're in a place that's outside of time," she says of her experience. "You feel like you're in eternity."

Dodge came away with the sense that, when she died, she'd be in that place of ?oneness and eternity? again. She says the comforting thought makes it easier to live today. Her energy is back and it?s "amazing," she explains.

Simply put: Osborne's business made Dodge look forward to an afterlife, and she found peace in this life.

And, to bring it back to business, Osborne's business is succeeding. He says his retreats are filling up fast. He makes more now than when he grew shrooms illegally. He pays taxes, and supports three kids. He hopes to expand to Portugal one day, where shrooms are decriminalized. "I'd like to see MycoMeditations become a global company," he adds.

Of course, Osborne has reservations about all this, mostly about the trip business expanding too fast. He says three times recently people have called him, wanting advice on how to get in on the loot. But without them having experience handling the "psychological crises" that happen during a bad mushroom trip, he's worried people will get hurt.

Because these drugs do have risks. Even most who champion psychedelics think they should in some way be controlled. For "sweet old ladies" like Diane Dodge who choose to do them of their own volition, a controlled setting that is regulated and insured and inspected and safe will likely be the norm.

Business. Industry. Corporations. Profit. To many people who do hallucinogens, those words sound like nails on a chalkboard. The drugs are supposed to be about peace, love, sharing, not money. Businesses, including corporate prisons and big pharma, it?s believed, have colluded with the crooked government to keep these drugs illegal. And so the idea that business and industry could be the things that bring these drugs out of the dark ages and to people like Dodge isn't just ridiculous, it's wrong, unethical, immoral.

"Tyler" is one person who believes this. He lives in Asia, and does much the same thing as Eric Osborne: giving people drugs to help them through their problems. But he "can't take money for it," he says. Working for months at a bank, Tyler saves up enough money and then drops out of the grind to go give out drugs for free. He sounds like a priest; like drugs are his eucharist.

"Tyler" and I met in Oakland this spring, at the Psychedelic Science 2017 conference, the largest of its kind in the history of the world. A lot of people there were like him, saying they could no more take money for these drugs than they could take money for having sex.

But quite a lot of people were open to the future of industry. A number of students from the University of Colorado Boulder Psychedelic Club had traveled there, eyeing this new class of drugs as a viable career opportunity. Nick Morris, for example, dreams of doing marketing for Alex Grey and Allyson Grey, two artists who are inspired by DMT. James Casey wiped out his PTSD with MDMA; now he wants to be a lab assistant for the Johns Hopkins magic mushroom studies.

Sure, a money-free world is the hippie dream. But "we live in a capitalist culture," Rick Doblin, the head of the Multidisciplinary Association for Psychedelic Studies (MAPS), which hosted the conference, says. "People need to make a living."

One Saturday morning at the conference, I sat at a table and had a discussion with Alex O'Bryan-Tear. He's a recent college graduate working at the Beckley Foundation, a psychedelic research nonprofit. He?s helping design the first scientific study of a promising new use of a hallucinogen: microdosing LSD ? a trending behavior in places like Silicon Valley.

"It's a new health fad, like it's acai berries or goji berries," he said.

This could be a big deal. In the 1960s, the Swiss chemical company Sandoz (where LSD was first cooked up in 1938), knew it had a powerful chemical on its hands. It gave away big batches for free to any researcher who wanted it, hoping that one of them would find an application Sandoz could market and profit off. No one did.

Until now.

Microdosing might just be that long sought-for profitable application. But it needs capital for the studies. Without it, there's less hope for an industry ? and for O'Bryan-Tear's career.

On the conference program that morning, in fine print, were these words: "Partner forum: Bicycle Day Ventures." The words meant nothing to me, and there was no explanation on the program, but O'Bryan-Tear knew, and he ended our conversation to check it out. With a spring in his step, he bounded upstairs and darted into a small room where 27 people listened to a man who seemed to have come from the future.

The man wore purple sneakers and habitually pushed his long hippie hair behind his ears. It was tech entrepreneur Chris Kantrowitz from Los Angeles, founder and CEO of Gobbler, a subscription service that helps musicians mix and record audio. John Legend and Jared Leto are invested in it.

Kantrowitz had a life-changing experience on ayahuasca once, and was wowed by fMRIs showing how magic mushrooms light up the brain. Now, as a sidelight, Kantrowitz is one of the heads of Bicycle Day Ventures, a venture capital fund dedicated to this new psychedelic space. He told the group, listening with attention, that he ha $10 million to invest in psychedelic startups. He wasn't sure what he wanted to invest in: a lab? A pharma company? A software developer? A college?

With all the confidence of the serial entrepreneur that he is, Kantrowitz said that money will flow, that psychedelic business will end up being on the scale the industries of alcohol, tobacco or cannabis. "There will be a few billion-dollar companies in this space," he said.

The room buzzed with excitement. These were people who had already made small bundles legally off ketamine, ayahuasca, cannabis and ibogaine.

O'Bryan-Tear, too, fidgeted in his seat, smiled, and rubbed his hands on his legs with excitement. He had a couple drugs in mind he thought someone might turn into a great medicine; some of the 2C's are nice, he claims. A brighter future seemed to come into view.

Psychedelic businesses already exist plenty, most of them are just illegal. However, gray market jobs around them thrive, like selling research chemicals that aren't illegal but mimic (or even improve upon) the effects of classic psychedelics.

As for people making money directly off psychedelics, legally, right now? There's actually a lot.

- Trip leaders of ibogaine tours in Mexico and mushroom retreats in the Netherlands.
- Labs that check the purity of street drugs, like Energy Control.
- Academics working on the scientific studies of hallucinogens in a few universities around the world, from Barcelona to Japan.
- Lab techs manufacturing those drugs for studies, at universities in Indiana and in private labs in San Diego, among others.
- Teachers training academics, like at the California Institute of Integral Studies in San Francisco, which offers a certification in psychedelic assisted therapies and research.
- All the realtors, lawyers, equipment manufacturers, janitors and so on that surround these enterprises.

Continued Like cannabis, wealthy investors are shoving millions of dollars into psychedelics | Rooster Magazine

MiamiBoyz · 10-15-2017, 03:21 AM

RandyRandy · 10-15-2017, 11:33 AM

It's starting. I got some DMT and mushrooms through a "church". Had to become a member, so they say it's legal. I sure wouldn't want to use that as a defense in court though. The mushrooms weren't great but the DMT was very good. Not as good as an ayahuasca trip, but no vomiting, so that's a plus.

mineistaken · 10-15-2017, 11:53 AM

Quote:

Originally Posted by RandyRandy

It's starting. I got some DMT and mushrooms through a "church". Had to become a member, so they say it's legal. I sure wouldn't want to use that as a defense in court though. The mushrooms weren't great but the DMT was very good. Not as good as an ayahuasca trip, but no vomiting, so that's a plus.

Stay quality, stay away from narcotics.

Best-In-BC · 10-16-2017, 08:25 AM

Quote:

Originally Posted by RandyRandy

It's starting. I got some DMT and mushrooms through a "church". Had to become a member, so they say it's legal. I sure wouldn't want to use that as a defense in court though. The mushrooms weren't great but the DMT was very good. Not as good as an ayahuasca trip, but no vomiting, so that's a plus.

CaptainHowdy · 10-16-2017, 08:32 AM

Quote:

Originally Posted by RandyRandy

It's starting. I got some DMT and mushrooms through a "church". Had to become a member, so they say it's legal. I sure wouldn't want to use that as a defense in court though. The mushrooms weren't great but the DMT was very good. Not as good as an ayahuasca trip, but no vomiting, so that's a plus.

You're a true psychonaut, RR ...

Barry-xlovecam · 10-16-2017, 01:42 PM

I am not sure of the legal status currently but Peyote (the precursor to organic mescaline) is part of Southwestern Native American peoples *herritage*.

Paul Markham · 10-16-2017, 01:47 PM

While drugs remain illegal criminals have a steady income.

10-15-2017, 02:20 AM	#1
wehateporn Promoting Debate on GFY Industry Role: Join Date: Apr 2007 Posts: 27,173	Like cannabis, wealthy investors are shoving millions of dollars into psychedelics This is a story about business, not about drugs. It's about a new field that will likely flourish in the next decade or two, one selling mushrooms and other psychedelics as legally as alcohol and marijuana are today. There will be DMT retreat centers, doctors who administer LSD microdoses, and centers that use ketamine to permanently cure depression. But first, to convince you this business is important, this business will matter to regular people, a tale must first be told: about a "sweet old lady" (as her friend calls her, despite her being only 59) who was once afraid of death. Diane Dodge was always straightlaced. She was a systems analyst. A college grad. A rule follower. But after doctors told her she'd be dead in three years from colorectal cancer, she decided it was time to do drugs. Much like the cancer, the anxiety of dying was also killing her. In the beginning, she thought about simply offing herself to get it over with. Then, she read an article in The New Yorker by Michael Pollan titled, "The Trip Treatment," which highlighted studies from Johns Hopkins and NYU showing that after a single dose of psilocybin mushrooms, cancer patients "who had been palpably scared of death, they lost their fear" ? as researcher Stephen Ross of NYU told Pollan. "The fact that a drug given once can have such an effect for so long is an unprecedented finding,? Ross continued. ?We have never had anything like it in the psychiatric field.? Diane Dodge wanted in. She lived in North Carolina, but called the distant university to offer herself as a subject anyway. They were full. This is where corporate industry stepped in. Business. By chance, Dodge found a newly created business that was going to help her. It was MycoMeditations, a company founded by a man named Eric Osborne that runs five-day mushroom trip getaways starting at just $1995. The price includes a room, two meals a day and a few opportunities to do mushrooms while sitting around a campfire on the beach. Because it?s in Jamaica, it?s perfectly legal, a fact Osborne caught wind of after being arrested for growing mushrooms in America years ago. Dodge went. She did drugs. As waves crashed on the beach, waves of light crashed inside her head. She hallucinated children, elves. "You're in a place that's outside of time," she says of her experience. "You feel like you're in eternity." Dodge came away with the sense that, when she died, she'd be in that place of ?oneness and eternity? again. She says the comforting thought makes it easier to live today. Her energy is back and it?s "amazing," she explains. Simply put: Osborne's business made Dodge look forward to an afterlife, and she found peace in this life. And, to bring it back to business, Osborne's business is succeeding. He says his retreats are filling up fast. He makes more now than when he grew shrooms illegally. He pays taxes, and supports three kids. He hopes to expand to Portugal one day, where shrooms are decriminalized. "I'd like to see MycoMeditations become a global company," he adds. Of course, Osborne has reservations about all this, mostly about the trip business expanding too fast. He says three times recently people have called him, wanting advice on how to get in on the loot. But without them having experience handling the "psychological crises" that happen during a bad mushroom trip, he's worried people will get hurt. Because these drugs do have risks. Even most who champion psychedelics think they should in some way be controlled. For "sweet old ladies" like Diane Dodge who choose to do them of their own volition, a controlled setting that is regulated and insured and inspected and safe will likely be the norm. Business. Industry. Corporations. Profit. To many people who do hallucinogens, those words sound like nails on a chalkboard. The drugs are supposed to be about peace, love, sharing, not money. Businesses, including corporate prisons and big pharma, it?s believed, have colluded with the crooked government to keep these drugs illegal. And so the idea that business and industry could be the things that bring these drugs out of the dark ages and to people like Dodge isn't just ridiculous, it's wrong, unethical, immoral. "Tyler" is one person who believes this. He lives in Asia, and does much the same thing as Eric Osborne: giving people drugs to help them through their problems. But he "can't take money for it," he says. Working for months at a bank, Tyler saves up enough money and then drops out of the grind to go give out drugs for free. He sounds like a priest; like drugs are his eucharist. "Tyler" and I met in Oakland this spring, at the Psychedelic Science 2017 conference, the largest of its kind in the history of the world. A lot of people there were like him, saying they could no more take money for these drugs than they could take money for having sex. But quite a lot of people were open to the future of industry. A number of students from the University of Colorado Boulder Psychedelic Club had traveled there, eyeing this new class of drugs as a viable career opportunity. Nick Morris, for example, dreams of doing marketing for Alex Grey and Allyson Grey, two artists who are inspired by DMT. James Casey wiped out his PTSD with MDMA; now he wants to be a lab assistant for the Johns Hopkins magic mushroom studies. Sure, a money-free world is the hippie dream. But "we live in a capitalist culture," Rick Doblin, the head of the Multidisciplinary Association for Psychedelic Studies (MAPS), which hosted the conference, says. "People need to make a living." One Saturday morning at the conference, I sat at a table and had a discussion with Alex O'Bryan-Tear. He's a recent college graduate working at the Beckley Foundation, a psychedelic research nonprofit. He?s helping design the first scientific study of a promising new use of a hallucinogen: microdosing LSD ? a trending behavior in places like Silicon Valley. "It's a new health fad, like it's acai berries or goji berries," he said. This could be a big deal. In the 1960s, the Swiss chemical company Sandoz (where LSD was first cooked up in 1938), knew it had a powerful chemical on its hands. It gave away big batches for free to any researcher who wanted it, hoping that one of them would find an application Sandoz could market and profit off. No one did. Until now. Microdosing might just be that long sought-for profitable application. But it needs capital for the studies. Without it, there's less hope for an industry ? and for O'Bryan-Tear's career. On the conference program that morning, in fine print, were these words: "Partner forum: Bicycle Day Ventures." The words meant nothing to me, and there was no explanation on the program, but O'Bryan-Tear knew, and he ended our conversation to check it out. With a spring in his step, he bounded upstairs and darted into a small room where 27 people listened to a man who seemed to have come from the future. The man wore purple sneakers and habitually pushed his long hippie hair behind his ears. It was tech entrepreneur Chris Kantrowitz from Los Angeles, founder and CEO of Gobbler, a subscription service that helps musicians mix and record audio. John Legend and Jared Leto are invested in it. Kantrowitz had a life-changing experience on ayahuasca once, and was wowed by fMRIs showing how magic mushrooms light up the brain. Now, as a sidelight, Kantrowitz is one of the heads of Bicycle Day Ventures, a venture capital fund dedicated to this new psychedelic space. He told the group, listening with attention, that he ha $10 million to invest in psychedelic startups. He wasn't sure what he wanted to invest in: a lab? A pharma company? A software developer? A college? With all the confidence of the serial entrepreneur that he is, Kantrowitz said that money will flow, that psychedelic business will end up being on the scale the industries of alcohol, tobacco or cannabis. "There will be a few billion-dollar companies in this space," he said. The room buzzed with excitement. These were people who had already made small bundles legally off ketamine, ayahuasca, cannabis and ibogaine. O'Bryan-Tear, too, fidgeted in his seat, smiled, and rubbed his hands on his legs with excitement. He had a couple drugs in mind he thought someone might turn into a great medicine; some of the 2C's are nice, he claims. A brighter future seemed to come into view. Psychedelic businesses already exist plenty, most of them are just illegal. However, gray market jobs around them thrive, like selling research chemicals that aren't illegal but mimic (or even improve upon) the effects of classic psychedelics. As for people making money directly off psychedelics, legally, right now? There's actually a lot. - Trip leaders of ibogaine tours in Mexico and mushroom retreats in the Netherlands. - Labs that check the purity of street drugs, like Energy Control. - Academics working on the scientific studies of hallucinogens in a few universities around the world, from Barcelona to Japan. - Lab techs manufacturing those drugs for studies, at universities in Indiana and in private labs in San Diego, among others. - Teachers training academics, like at the California Institute of Integral Studies in San Francisco, which offers a certification in psychedelic assisted therapies and research. - All the realtors, lawyers, equipment manufacturers, janitors and so on that surround these enterprises. Continued Like cannabis, wealthy investors are shoving millions of dollars into psychedelics \| Rooster Magazine __________________ Sexy Girls Teasing

10-16-2017, 01:47 PM	#8
Paul Markham Too old to care Industry Role: Join Date: Jun 2001 Location: On the sofa, watching TV or doing my jigsaws. Posts: 52,943	While drugs remain illegal criminals have a steady income. __________________ Blowout deal. 880 videos, 2,400 image sets, plus many RAW videos. $500. PM me for a deal. Skype Paulmarkham70

10-15-2017, 03:21 AM	#2
MiamiBoyz fgfdftre6 Industry Role: Join Date: Oct 2012 Location: In the closet with your dad! Posts: 6,690

10-15-2017, 11:33 AM	#3
RandyRandy Clips still sell! Industry Role: Join Date: Jul 2012 Location: Crown Heights, Brooklyn Posts: 1,708	It's starting. I got some DMT and mushrooms through a "church". Had to become a member, so they say it's legal. I sure wouldn't want to use that as a defense in court though. The mushrooms weren't great but the DMT was very good. Not as good as an ayahuasca trip, but no vomiting, so that's a plus.

10-16-2017, 01:42 PM	#7
Barry-xlovecam It's 42 Industry Role: Join Date: Jun 2010 Location: Global Posts: 18,083	I am not sure of the legal status currently but Peyote (the precursor to organic mescaline) is part of Southwestern Native American peoples herritage.